Alemtuzumab Consolidation Does Not Improve Outcome for CLL Patients with High Risk Genomic Features on Successive CALGB Trials.

作者:Jones Jeffrey A; Stark Amy; Zhao Weiqiang; Lin Thomas S; Rai Kanti R; Marcucci Guido; Peterson Bercedis; Larson Richard A; Heerema Nyla A; Byrd John C
来源:53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, 2011-12-10 to 2011-12-13.